EUVIMEDEUVIMED entdecken
Crossref

Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma

S Thul, L M Reindl, P Wendel, M C Burger, J P Steinbach, W S Wels

Klinische Pädiatrie · 01.05.2024 · 236 (03) · 215

DOI: 10.1055/s-0044-1786625 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Klinische Pädiatrie, erschienen am 01.05.2024. Verfasst von S Thul und 5 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma

Zitieren

APA

Thul, S., Reindl, L. M., Wendel, P., Burger, M. C., Steinbach, J. P., & Wels, W. S. (2024). Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma. Klinische Pädiatrie, 236(03), 215. https://doi.org/10.1055/s-0044-1786625

Vancouver

Thul S, Reindl LM, Wendel P, Burger MC, Steinbach JP, Wels WS. Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma. Klinische Pädiatrie. 2024;236(03):215. doi:10.1055/s-0044-1786625

BibTeX
@article{Thul2024,
  author = {Thul, S and Reindl, L M and Wendel, P and Burger, M C and Steinbach, J P and Wels, W S},
  title = {Primary CAR-NK cells targeting B7-H3 as a novel experimental immunotherapeutic strategy against glioblastoma},
  journal = {Klinische Pädiatrie},
  year = {2024},
  volume = {236},
  number = {03},
  pages = {215},
  doi = {10.1055/s-0044-1786625}
}
Kostenlos starten →